NO20055466D0 - Dispersible pharmaceutical composition for treating mastitis and otic disorders - Google Patents

Dispersible pharmaceutical composition for treating mastitis and otic disorders

Info

Publication number
NO20055466D0
NO20055466D0 NO20055466A NO20055466A NO20055466D0 NO 20055466 D0 NO20055466 D0 NO 20055466D0 NO 20055466 A NO20055466 A NO 20055466A NO 20055466 A NO20055466 A NO 20055466A NO 20055466 D0 NO20055466 D0 NO 20055466D0
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
otic disorders
treating mastitis
dispersible pharmaceutical
dispersible
Prior art date
Application number
NO20055466A
Other languages
Norwegian (no)
Other versions
NO20055466L (en
Inventor
Niki Ann Waldron
Nancy Jean Britten
John W Hallberg
Jeffrey Watts
Iii John Williams Burns
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NO20055466D0 publication Critical patent/NO20055466D0/en
Publication of NO20055466L publication Critical patent/NO20055466L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Packages (AREA)
  • Medicinal Preparation (AREA)
NO20055466A 2003-07-31 2005-11-18 Dispersible pharmaceutical composition for treating mastitis and otic disorders NO20055466L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49217803P 2003-07-31 2003-07-31
PCT/IB2004/002474 WO2005009472A2 (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Publications (2)

Publication Number Publication Date
NO20055466D0 true NO20055466D0 (en) 2005-11-18
NO20055466L NO20055466L (en) 2006-04-21

Family

ID=34103028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055466A NO20055466L (en) 2003-07-31 2005-11-18 Dispersible pharmaceutical composition for treating mastitis and otic disorders

Country Status (13)

Country Link
EP (1) EP1656159A2 (en)
JP (1) JP2007500692A (en)
KR (1) KR100807414B1 (en)
CN (1) CN1812814A (en)
AU (1) AU2004258746A1 (en)
BR (1) BRPI0412923A (en)
CA (1) CA2529405A1 (en)
IL (1) IL171893A0 (en)
MX (1) MXPA06001192A (en)
NO (1) NO20055466L (en)
RU (1) RU2329064C2 (en)
WO (1) WO2005009472A2 (en)
ZA (1) ZA200600850B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2292122T3 (en) * 2004-04-22 2008-03-01 Pfizer Products Incorporated DISORDERED CEFOVECINE SODIUM SALT STABILIZATION PROCEDURE.
KR20150030707A (en) * 2012-06-29 2015-03-20 바이엘 애니멀 헬스 게엠베하 Pharmaceutical compositions and treatment of mastitis
RU2016101960A (en) * 2013-08-12 2017-09-18 Новартис Аг METHOD FOR TREATING EAR INFECTIONS AFTER INSTALLING A TYPMANOSTOMIC TUBE
CN104622875B (en) * 2015-02-12 2017-05-10 江西博莱大药厂有限公司 Breast injection medicament for resisting cow mastitis and preparation method thereof
ES2907686T3 (en) * 2015-11-03 2022-04-26 Zoetis Services Llc Sol-gel polymeric compounds and their uses
RU2663070C1 (en) * 2017-05-04 2018-08-01 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Method for otomycosis treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69620136T2 (en) * 1995-06-06 2002-08-01 Bayer Ag ANTIBACTERIAL PREPARATIONS FOR THE EARS WITHOUT IRRITATING, SENSITIZING AND OTOTOXIC EFFECTS
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid

Also Published As

Publication number Publication date
RU2006102665A (en) 2006-06-10
ZA200600850B (en) 2007-05-30
KR20060033031A (en) 2006-04-18
AU2004258746A1 (en) 2005-02-03
NO20055466L (en) 2006-04-21
WO2005009472A2 (en) 2005-02-03
WO2005009472A3 (en) 2005-04-07
RU2329064C2 (en) 2008-07-20
KR100807414B1 (en) 2008-02-25
CA2529405A1 (en) 2005-02-03
MXPA06001192A (en) 2006-04-11
CN1812814A (en) 2006-08-02
IL171893A0 (en) 2006-04-10
JP2007500692A (en) 2007-01-18
EP1656159A2 (en) 2006-05-17
BRPI0412923A (en) 2006-09-26

Similar Documents

Publication Publication Date Title
PL1644021T3 (en) Methods and compositions for the treatment of gastrointestinal disorders
NO20034056D0 (en) Proliferative diseases
NO20032220D0 (en) Löfteverktöy II and method for using the same
AUPS323902A0 (en) Compositions and methods for treating gynaecological disorders
WO2004058164A3 (en) Asthma and allergic inflammation modulators
NO20040097L (en) Combinations for the treatment of inflammatory disorders
NO20050570L (en) New compounds, preparations and methods for the treatment of inflammatory diseases and conditions
IS8410A (en) Methods and Reagents for the Treatment of Immune Inflammatory Disorders
HK1098383A1 (en) Compositions and methods for treating coagulation related disorders
WO2005091853A3 (en) Methods and compositions for treating il-13 related pathologies
WO2004113277A8 (en) Methods and compositions for treating amyloid-related diseases
HK1203216A1 (en) Materials and methods for treating disorders of the ear
HK1103631A1 (en) Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
IL175610A0 (en) Methods and reagents for the treatment of inflammatory disorders
NO20055466D0 (en) Dispersible pharmaceutical composition for treating mastitis and otic disorders
NO20041386L (en) Combinations for the treatment of immuno-inflammatory disorders
DE60036249D1 (en) Field effect transistor and its production method
EP1648417A4 (en) Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
WO2005007094A3 (en) Asthma and allergic inflammation modulators
DE502004010131D1 (en) PYRIDOPYRIMIDINONE FOR THE TREATMENT OF CANCER DISORDERS
WO2005044200A3 (en) Methods and compositions for treating mcp-1 related pathologies
BR0318172B1 (en) "impedance matching device, and method for manufacturing the same"
NO20052188D0 (en) Polysulfide Preparation System and Process
WO2002068476A3 (en) Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
AU2002241343A1 (en) Decoy compositions for treating and preventing brain diseases and disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application